Larimar Therapeutics Inc.
LRMR | NASDAQ
$3.83
+$0.04 (+1.06%)
At close: Sep 21, 2026, 4:00 PM ET
$3.83
$0 (0.00%)
Pre-market:
Sep 22, 2026, 8:05 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.68 | -2.93 | -5.42 | -3.11 | -3.68 | -6.01 |
PEG Ratio | -0.02 | -0.05 | 0.15 | 0.06 | 0.21 | -0.14 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.56 | 1.38 | 2.44 | 0.96 | 2.88 | 2.84 |
P/FCF Ratio | -2.45 | -3.33 | -5.94 | -3.85 | -4.36 | -6.02 |
P/OCF Ratio | -2.46 | -3.35 | -5.97 | -3.86 | -4.40 | -6.03 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.05 | 0.03 | 0.07 | 0.05 | 0.09 | 0.07 |
Quick Ratio | 2.19 | 8.02 | 9.49 | 11.28 | 8.16 | 10.89 |
Current Ratio | 2.19 | 8.02 | 9.49 | 11.28 | 8.16 | 10.89 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -212.17% | -46.91% | -45.21% | -31.88% | -78.61% | -47.19% |
Return on Assets | -113.60% | -40.26% | -38.51% | -27.97% | -64.37% | -40.43% |
Return on Invested Capital | -209.97% | -51.37% | -47.85% | -31.40% | -71.67% | -44.49% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove LRMR